Lilly pill leads to 7.9% weight loss at 40 weeks in trial

  • Eli Lilly said on Thursday its experimental pill, orforglipron, led to an average weight loss of 7.9% and lowered blood sugar for overweight patients with type 2 diabetes in a late-stage trial.